MTOR and gastric cancer: Autophagy inducers, such as mTOR inhibitors in cases of GC-disseminated-type or AMPK homeostatic pathway activators such as the antibiotic substance Tigecycline [35], could be used in cases of chemoresistant GC, in which other anti-cancer treatments failed to reduce the cancer progression.